| 中文名 | 5-甲酰基噻唑-2-氨基甲酸叔丁酯 |
|---|---|
| 英文名 | tert-butyl N-(5-formyl-1,3-thiazol-2-yl)carbamate |
| 中文别名 | (5-甲酰基-2-噻唑)-氨基甲酸叔丁酯 |
| 英文别名 |
Carbamic acid, N-(5-formyl-2-thiazolyl)-, 1,1-dimethylethyl ester
tert-Butyl (5-formyl-1,3-thiazol-2-yl)carbamate 2-Methyl-2-propanyl (5-formyl-1,3-thiazol-2-yl)carbamate |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 分子式 | C9H12N2O3S |
| 分子量 | 228.268 |
| 精确质量 | 228.056870 |
| PSA | 96.53000 |
| LogP | 1.29 |
| 折射率 | 1.603 |
| 储存条件 | -20°C,干燥,密封 |
| 危害码 (欧洲) | Xi |
|---|---|
| 海关编码 | 2934100090 |
|
~91%
391668-77-2 |
| 文献:McCormick, Kevin D.; Aslanian, Robert G.; Mangiaracina, Pietro; Berlin, Michael Y.; De Lera Ruiz, Manuel; Boyce, Christopher W.; Chao, Jianhua; Ting, Pauline C.; Zheng, Junying; Rosenblum, Stuart B. Patent: US2011/166124 A1, 2011 ; Location in patent: Page/Page column 42 ; |
|
~%
391668-77-2 |
| 文献:Schering Corporation Patent: US2007/167435 A1, 2007 ; Location in patent: Page/Page column 46 ; US 20070167435 A1 |
|
~%
391668-77-2 |
| 文献:Mitsubishi Tanabe Pharma Corporation Patent: EP2105435 A1, 2009 ; Location in patent: Page/Page column 54 ; |
|
~%
391668-77-2 |
| 文献:McCormick, Kevin D.; Aslanian, Robert G.; Mangiaracina, Pietro; Berlin, Michael Y.; De Lera Ruiz, Manuel; Boyce, Christopher W.; Chao, Jianhua; Ting, Pauline C.; Zheng, Junying; Rosenblum, Stuart B. Patent: US2011/166124 A1, 2011 ; |
|
~%
391668-77-2 |
| 文献:McCormick, Kevin D.; Aslanian, Robert G.; Mangiaracina, Pietro; Berlin, Michael Y.; De Lera Ruiz, Manuel; Boyce, Christopher W.; Chao, Jianhua; Ting, Pauline C.; Zheng, Junying; Rosenblum, Stuart B. Patent: US2011/166124 A1, 2011 ; |
| 上游产品 6 | |
|---|---|
| 下游产品 2 | |
| 海关编码 | 2934100090 |
|---|---|
| 中文概述 | 2934100090. 结构上含有一个非稠合噻唑环的化合物(不论是否氢化). 增值税率:17.0%. 退税率:9.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |